Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACLY | P53396 | 2/20 | 0.81 |
| ▸ | ACACA | Q13085 | 2/20 | 0.81 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.62 |
| ▸ | USP2 | O75604 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.54 |
| ▸ | CRYAB | P02511 | 1/20 | 0.54 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.52 |
| ▸ | HSD11B2 | P80365 | 1/20 | 0.52 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.51 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.51 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.46 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.45 |
| ▸ | ACHE | P22303 | 3/20 | 0.44 |
| ▸ | HMGCR | P04035 | 1/20 | 0.42 |
| ▸ | PTGES | O14684 | 3/20 | 0.42 |
| ▸ | FNTA | P49354 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cycloartenol SCHEMBL12368108 | 1.00 | ACLY (0.81) | ACLYACACAPTPN11USP2ALDH1A1 | |
| Cycloartenol SCHEMBL13644393 | 1.00 | ACLY (0.81) | ACLYACACAPTPN11USP2ALDH1A1 | |
| Cycloartenol SCHEMBL13455189 | 1.00 | ACLY (0.81) | ACLYACACAPTPN11USP2ALDH1A1 | |
| Cycloartenol SCHEMBL8283290 | 1.00 | ACLY (0.81) | ACLYACACAPTPN11USP2ALDH1A1 | |
| Cycloartenol SCHEMBL13420259 | 1.00 | ACLY (0.81) | ACLYACACAPTPN11USP2ALDH1A1 | |
| Cycloartenol SCHEMBL23754759 | 1.00 | ACLY (0.81) | ACLYACACAPTPN11USP2ALDH1A1 | |
| Cycloartenol SCHEMBL10034117 | 1.00 | ACLY (0.81) | ACLYACACAPTPN11USP2ALDH1A1 | |
| Cycloartenol SCHEMBL21754440 | 1.00 | ACLY (0.81) | ACLYACACAPTPN11USP2ALDH1A1 | |
| Cycloartenol SCHEMBL20778271 | 1.00 | ACLY (0.81) | ACLYACACAPTPN11USP2ALDH1A1 | |
| Cycloartenol SCHEMBL17057018 | 1.00 | ACLY (0.81) | ACLYACACAPTPN11USP2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260027136-A1 | CANNABIS BASED THERAPEUTIC AND METHOD OF USE | YUZU LV LLC (US) | 2026-01-29 | — | — | US | claimed |
| CN-115925775-B | Triterpene compound, preparation method and application thereof | 台州学院 | 2025-02-28 | — | — | CN | claimed |
| EP-4323006-A1 | MONOACYLGLYCEROL AND FREE FATTY ACID-BASED COMPOSITIONS, METHODS OF MANUFACTURING AND USE OF THE SAME | GlycosBio Inc. (US) | 2024-02-21 | — | — | EP | claimed |
| EP-4323005-A1 | DRUG DELIVERY VIA MONOACYLGLYCEROL AND FREE FATTY ACID-BASED COMPOSITIONS | GlycosBio Inc. (US) | 2024-02-21 | — | — | EP | claimed |
| CN-116426166-A | Preparation of odor-free environment-friendly bio-based color paste | 明光科迪新材料有限公司 | 2023-07-14 | — | — | CN | claimed |
| CN-110300575-B | Extract of celastrus orbiculatus rattan, cosmetic composition comprising same and cosmetic use thereof | ISP投资有限公司 | 2022-11-15 | — | — | CN | claimed |
| WO-2022221470-A1 | DRUG DELIVERY VIA MONOACYLGLYCEROL AND FREE FATTY ACID-BASED COMPOSITIONS | GLYCOSBIO INC. (US) | 2022-10-20 | — | — | WO | claimed |
| WO-2022221472-A1 | MONOACYLGLYCEROL AND FREE FATTY ACID-BASED COMPOSITIONS, METHODS OF MANUFACTURING AND USE OF THE SAME | GLYCOSBIO INC. (US) | 2022-10-20 | — | — | WO | claimed |
| US-11400389-B2 | Marsdenia cundurango creeper extracts, cosmetic compositions comprising them and cosmetic uses of same | ISP INVESTMENTS LLC (US) | 2022-08-02 | — | — | US | claimed |
| EP-4017486-A1 | COMPOSITONS FOR THE TREATMENT OF A CONDITION CHARACTERIZED BY ANANDAMIDE DEFICIENCY AND USES THEREOF | Buzzelet Development And Technologies Ltd (IL) | 2022-06-29 | — | — | EP | claimed |
| EP-3579929-B1 | MARSDENIA CUNDURANGO | ISP INVESTMENTS LLC (US) | 2022-04-13 | — | — | EP | claimed |
| WO-2026047603-A1 | SARS-COV-2 IMMUNOGENIC COMPOSITIONS | BioNTech SE (DE) | 2026-03-05 | — | — | WO | disclosed |
| CN-120131882-A | Preparation method of white jade powder soup | 四川省中西医结合医院 | 2025-06-13 | — | — | CN | disclosed |
| CN-120041091-A | Soil release coating composition, substrate coated with such coating composition, and use of such coating composition | 阿克佐 诺贝尔国际涂料股份有限公司 | 2025-05-27 | — | — | CN | disclosed |
| US-12275862-B2 | Foul release coating composition | AKZO NOBEL COATINGS INTERNATIONAL B.V. (NL) | 2025-04-15 | — | — | US | disclosed |
| US-20050086713-A1 | Transgenic plants containing altered levels of steroid compounds | KARUNANANDAA BALASULOJINI (US) | 2005-04-21 | — | — | US | disclosed |
| US-6822142-B2 | COMPRISES DNA ENCODING 3-HYDROXY-3-METHYLGLUTARYL-COENZYME A REDUCTASE AND TOCOPHEROL SYNTHETASE; SQUALENE EPOXIDASE; ADMINISTERING ENZYME EXTRACT TO HUMANS FOR LOWERING THE PLASMA CONCENTRATION OF LOW DENSITY LIPOPROTEIN CHOLESTEROL | MONSANTO COMPANY | 2004-11-23 | — | — | US | disclosed |
| US-20030150008-A1 | Transgenic plants containing altered levels of steroid compounds | MONSANTO TECHNOLOGY, L.L.C. | 2003-08-07 | — | — | US | disclosed |
| US-5589619-A | INCREASING THE AMOUNT OF A GENE ENCODING A POLYPEPTIDE HAVING HMG-COA REDUCTASE ACTIVITY | AMOCO CORPORATION (US) | 1996-12-31 | — | — | US | disclosed |
| US-5349126-A | Transforming with vector linked to DNA segment that encodes polypeptide with 3-hydroxy-3-methylglutaryl CoA reductase activity; insecticides | AMOCO CORPORATION (US) | 1994-09-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11400389-B2 | Marsdenia cundurango creeper extracts, cosmetic compositions comprising them and cosmetic uses of same | CUTA, TYR, TPSD1 | ACLY 932/4885ACACA 490/4885PTPN11 4000/4885 |
| US-20030150008-A1 | Transgenic plants containing altered levels of steroid compounds | HMGCR, CYP11A1, CYP46A1 | ACLY 534/4885ACACA 76/4885PTPN11 4204/4885 |
| US-20260027136-A1 | CANNABIS BASED THERAPEUTIC AND METHOD OF USE | CNR1, CNR2, OPRM1 | ACLY 1427/4885ACACA 116/4885PTPN11 2356/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.